Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

1

Egypt. J. Exp. Biol. (Bot.). 2014; 10(1): 1-12


BIOSYNTHESIS OF SILVER NANOPARTICLES USING FUNGI AND BIOLOGICAL EVALUATION OF MYCOSYNTHESIZED SILVER NANOPARTICLES

Hany M. Magdi Mohamed H. E. Mourad Marwa M. Abd El-Aziz.

Abstract
Eight fungal species were screened for mycosynthesis of silver nanaoparticles (AgNPs), by visual observation of fungal filtrate only six fungal species were found to reduce the silver salt into silver nanoparticles. The UV-visible spectra of the biosynthesized nanoparticles (AgNPs) by Aspergillus ochraceus (RCMB 036254) cell filtrate showed characteristic surface plasmon absorption at 420 nm. Transmission electron microscopy (TEM) micrograph showed the formation of spherical AgNPs ranging from 5.5 to 24.5 nm diameter. The Qualitative, as well as quantitative status of elemental silver was characterized by Energy Dispersive Analysis of X-ray (EDX). The optimum conditions for maximum production of AgNPs were obtained using 0.75 mM silver nitrate at 40C and pH 6. The antimicrobial activity of the mycosynthesized nanoparticles under optimum conditions were investigated alone and in combination with commonly used antibiotics against Methicillin-resistant Staphylococcus aureus (MRSA). Out of thirteen commonly used antibiotics, the antibacterial efficiency of only five antibiotics has been increased as a result of combination with AgNPs. Biosynthesized silver nanoparticles showed dose-dependent antitumor activity with IC50 at 1.4, 2.1, and 1.2 g/ml against human colon carcinoma, human breast cancer and human hepato-cellular carcinoma cells, respectively, while 39.6 g/ml was required to induce 50% of normal Vero cell mortality.

Key words: Biosynthesis, silver nanoparticles, mycosynthesized silver nanoparticles



Share this Article


Advertisement
Journal of Contemporary Medical Education

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
ScopeMed Home
Follow ScopeMed on Twitter
BiblioCAM
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.
Scopemed Buttons